Vantive Drug Patent Portfolio
Vantive owns 1 orange book drug protected by 2 US patents Given below is the list of Vantive's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6248726 | Method of peritoneal dialysis using glucose polymer solutions | 19 Jun, 2018 | Expired |
| US6077836 | Peritoneal dialysis and compositions for use therein | 20 Jun, 2017 | Expired |
Vantive's Drug Patent Litigations
Vantive's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 01, 1, against patent number US6077836. The petitioner , challenged the validity of this patent, with MILNER as the respondent. Click below to track the latest information on how companies are challenging Vantive's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6248726 | May, 1995 |
Decision
(28 Aug, 2000)
| ALSOP et al | |
| US6077836 | January, 1 |
Decision
(14 Sep, 1999)
| MILNER | |
Vantive's Family Patents
Vantive Drug List
Given below is the complete list of Vantive's drugs and the patents protecting them.
1. Extraneal
Extraneal is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6248726 | Method of peritoneal dialysis using glucose polymer solutions |
19 Jun, 2018
(7 years ago)
| Expired |
| US6077836 | Peritoneal dialysis and compositions for use therein |
20 Jun, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Extraneal's drug page